P-294Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. (20th June 2018) - Kato, T; Satake, H; Oba, K; Kagawa, Y; Yasui, H; Nakamura, M; Watanabe, T; Matsumoto, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; et al.